3/27
12:40 pm
vnrx
VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/27
10:08 am
vnrx
VolitionRx Limited (NYSE: VNRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $2.50 price target on the stock.
Low
Report
VolitionRx Limited (NYSE: VNRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $2.50 price target on the stock.
3/25
04:15 pm
vnrx
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update [Yahoo! Finance]
Medium
Report
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update [Yahoo! Finance]
3/25
04:10 pm
vnrx
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
Medium
Report
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
3/21
08:30 am
vnrx
VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
Medium
Report
VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
3/20
08:40 am
vnrx
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan [Yahoo! Finance]
Medium
Report
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan [Yahoo! Finance]
3/20
08:30 am
vnrx
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
Medium
Report
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
3/19
04:35 pm
vnrx
Volition appoints Dr Andrew Retter as Chief Medical Officer [Yahoo! Finance]
Medium
Report
Volition appoints Dr Andrew Retter as Chief Medical Officer [Yahoo! Finance]
3/19
04:30 pm
vnrx
Volition appoints Dr Andrew Retter as Chief Medical Officer
Medium
Report
Volition appoints Dr Andrew Retter as Chief Medical Officer
2/2
08:12 am
vnrx
Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar [Yahoo! Finance]
Low
Report
Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar [Yahoo! Finance]
2/2
08:00 am
vnrx
Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar
Low
Report
Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar
1/12
08:09 am
vnrx
Antech launches breakthrough in-hospital innovation, Nu.Q® Canine Cancer Test [Yahoo! Finance]
High
Report
Antech launches breakthrough in-hospital innovation, Nu.Q® Canine Cancer Test [Yahoo! Finance]
1/4
08:09 am
vnrx
Volition Issues Business Review 2023 [Yahoo! Finance]
High
Report
Volition Issues Business Review 2023 [Yahoo! Finance]
1/4
08:00 am
vnrx
Volition Issues Business Review 2023
High
Report
Volition Issues Business Review 2023
1/2
02:02 pm
vnrx
VolitionRx Shares Up 35% on $13M Milestone Payments From Heska [MarketWatch]
Medium
Report
VolitionRx Shares Up 35% on $13M Milestone Payments From Heska [MarketWatch]